Constructing immunoprofiles to deconstruct disease complexity in pemphigus

References

• Sinha AA, Brautbar C, Szafer F, Friedmann A, Tzfoni E, Todd JA, Steinman L, McDevitt HO. A newly characterized HLA DQ beta allele associated with pemphigus vulgaris. Science. 1988; 239:1026–1029.
   PubMed Web of Science ®Google Scholar
• Sinha AA, Lopez MT, McDevitt HO. Autoimmune diseases: The failure of self tolerance. Science. 1990; 248:1380–1388.
   PubMed Web of Science ®Google Scholar
• Todd JA, Acha-Orbea H, Bell JI, Chao N, Fronek Z, Jacob CO, McDermott M, Sinha AA, Timmerman L, Steinman L. A molecular basis for MHC class II—associated autoimmunity. Science. 1988; 240:1003–1009.
   PubMed Web of Science ®Google Scholar
• Scharf SJ, Friedmann A, Brautbar C, Szafer F, Steinman L, Horn G, Gyllensten U, Erlich HA. HLA class II allelic variation and susceptibility to pemphigus vulgaris. Proc Natl Acad Sci USA. 1988; 85:3504–3508.
   PubMed Web of Science ®Google Scholar
• Lee E, Lendas KA, Chow S, Pirani Y, Gordon D, Dionisio R, Nguyen D, Spizuoco A, Fotino M, Zhang Y, Sinha AA. Disease relevant HLA class II alleles isolated by genotypic, haplotypic, and sequence analysis in North American Caucasians with pemphigus vulgaris. Hum Immunol. 2006; 67:125–139.
   PubMed Web of Science ®Google Scholar
• Arora SK. Analysis of intracellular cytokines using flowcytometry. Meth Cell Sci. 2002; 24:37–40.
   PubMedGoogle Scholar
• Becker BA, Gaspari AA. Pemphigus vulgaris and vegetans. Dermatol Clin. 1993; 11:429–452.
   PubMed Web of Science ®Google Scholar
• Chow S, Rizzo C, Ravitskiy L, Sinha AA. The role of T cells in cutaneous autoimmune disease. Autoimmunity. 2005; 38:303–317.
   PubMed Web of Science ®Google Scholar
• Eming R, Bu¨dinger L, Riechers R, Christensen O, Bohlen H, Kalish R, Hertl M. Frequency analysis of autoreactive T-helper 1 and 2 cells in bullous pemphigoid and pemphigus vulgaris by enzyme-linked immunospot assay. Br J Dermatol. 2000; 143:1279–1282.
   PubMed Web of Science ®Google Scholar
• Hertl M, Eming R, Veldman C. T cell control in autoimmune bullous skin disorders. J Clin Invest. 2006; 116:1159–1166.
   PubMed Web of Science ®Google Scholar
• Hertl M, Riechers R. Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris. J Dermatol. 1999; 26:748–752.
   PubMedGoogle Scholar
• Rizzo C, Fotino M, Zhang Y, Chow S, Spizuoco A, Sinha AA. Direct characterization of human T cells in pemphigus vulgaris reveals elevated autoantigen-specific Th2 activity in association with active disease. Clin Exp Dermatol. 2005; 30:535–540.
   PubMed Web of Science ®Google Scholar
• Veldman C, Pahl A, Beissert S, Hansen W, Buer J, Dieckmann D, Schuler G, Hertl M. Inhibition of the transcription factor Foxp3 converts desmoglein 3-specific type 1 regulatory T cells into Th2-like cells. J Immunol. 2006; 176:3215–3222.
   PubMed Web of Science ®Google Scholar
• Moesta, AK, Rammensee HG, Lin MS, Sinha AA. An HLA class II peptide binding motif-based approach to identify T cell epitopes in pemphigus vulgaris. J Invest Dermatol. 2000; 114:846.
   Google Scholar
• Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L, Bystryn JC, Cianchini G, Diaz L, Fivenson D, Hall R, Harman KE, Hashimoto T, Hertl M, Hunzelmann N, Iranzo P, Joly P, Jonkman MF, Kitajima Y, Korman NJ, Martin LK, Mimouni D, Pandya AG, Payne AS, Rubenstein D, Shimizu H, Sinha AA, Sirois D, Zillikens D, Werth VP. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008; 58:1043–1046.
   PubMed Web of Science ®Google Scholar
• Sugiyama H, Matsue H, Nagasaka A, Nakamura Y, Tsukamoto K, Shibagaki N, Kawamura T, Kitamura R, Ando N, Shimada S. CD4+CD25high regulatory T cells are markedly decreased in blood of patients with pemphigus vulgaris. Dermatology. 2007; 214:210–220.
   PubMed Web of Science ®Google Scholar
• Veldman C, Pahl A, Hertl M. Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3. Immunology. 2009; 127:40–49.
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Eder R, Boeld TJ, Doser K, Piseshka B, Andreesen R, Edinger M. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion. Blood. 2006; 108:4260–4267.
   PubMed Web of Science ®Google Scholar
• James EA, Kwok WW. CD8+ suppressor-mediated regulation of human CD4+T cell responses to glutamic acid decarboxylase 65. Eur J Immunol. 2007; 37:78–86.
   PubMed Web of Science ®Google Scholar
• Rifa'i M, Kawamoto Y, Nakashima I, Suzuki H.. Essential roles of CD8+CD122+ regulatory T cells in the maintenance of T cell homeostasis. J Exp Med. 2004; 200:1123–1134.
   PubMed Web of Science ®Google Scholar
• Arbour N, Lapointe R, Saikali P, McCrea E, Regen T, Antel JP.. A new clinically relevant approach to expand myelin specific T cells. J Immunol Meth. 2006; 310:53–61.
   PubMed Web of Science ®Google Scholar
• Wucherpfennig KW, Yu B, Bhol K, Monos DS, Argyris E, Karr RW, Ahmed AR, Strominger JL.. Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: Charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. Proc Natl Acad Sci U S A. 1995; 92:11935–11939.
   PubMed Web of Science ®Google Scholar
• Lin MS, Swartz SJ, Lopez A, Ding X, Fernandez-Vina MA, Stastny P, Fairley JA, Diaz LA.. Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest. 1997; 99:31–40.
   PubMed Web of Science ®Google Scholar
• Veldman C, Stauber A, Wassmuth R, Uter W, Schuler G, Hertl M.. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles. J Immunol. 2003; 170:635–642.
   PubMed Web of Science ®Google Scholar
• Veldman CM, Gebhard KL, Uter W, Wassmuth R, Grotzinger J, Schultz E, Hertl M.. T cell recognition of desmoglein 3 peptides in patients with pemphigus vulgaris and healthy individuals. J Immunol. 2004; 172:3883–3892.
   PubMed Web of Science ®Google Scholar
• Baroni A, Perfetto B, Ruocco E, Greco R, Criscuolo D, Ruocco V.. Cytokine pattern in blister fluid and sera of patients with pemphigus. Dermatology. 2002; 205:116–121.
   PubMed Web of Science ®Google Scholar
• Ludwig RJ, Schmidt E. Cytokines in autoimmune bullous skin diseases. Epiphenomena or contribution to pathogenesis?. G Ital Dermatol Venereol. 2009; 144:339–349.
   PubMed Web of Science ®Google Scholar
• Satyam A, Khandpur S, Sharma VK, Sharma A.. Involvement of T(H)1/T(H)2 cytokines in the pathogenesis of autoimmune skin disease-Pemphigus vulgaris. Immunol Invest. 2009; 38:498–509.
   PubMed Web of Science ®Google Scholar
• Opreanu CR, Seiffert K, Sinha AA. Multiplexed array analysis supports disease phase related cytokine profiles in pemphigus vulgaris. J Invest Dermatol. 2008; 128:86.
   Web of Science ®Google Scholar
• Fiorentino DF, Garcia MS, Rehmus W, Kimball AB.. A pilot study of etanercept treatment for pemphigus vulgaris. Arch Dermatol. 2011; 147:117–118.
   PubMedGoogle Scholar
• Shetty A, Marcum CB, Glass LF, Carter JD.. Successful treatment of pemphigus vulgaris with etanercept in four patients. J Drugs Dermatol. 2009; 8:940–943.
   PubMed Web of Science ®Google Scholar
• Arakawa M, Dainichi T, Yasumoto S, Hashimoto T.. Lesional Th17 cells in pemphigus vulgaris and pemphigus foliaceus. J Dermatol Sci. 2009; 53:228–231.
   PubMed Web of Science ®Google Scholar
• Toto P, Feliciani C, Amerio P, Suzuki H, Wang B, Shivji GM, Woodley D, Sauder DN.. Immune modulation in pemphigus vulgaris: Role of CD28 and IL-10. J Immunol. 2000; 164:522–529.
   PubMed Web of Science ®Google Scholar
• Amagai M, Klaus-Kovtun V, Stanley JR. Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion. Cell. 1991; 67:869–877.
   PubMed Web of Science ®Google Scholar
• Mahoney MG, Wang ZH, Stanley JR. Pemphigus vulgaris and pemphigus foliaceus antibodies are pathogenic in plasminogen activator knockout mice. J Invest Dermatol. 1999; 113:22–25.
   PubMed Web of Science ®Google Scholar
• Kalish RS. Pemphigus vulgaris: The other half of the story. J Clin Invest. 2000; 106:1433–1435.
   PubMed Web of Science ®Google Scholar
• Kalantari-Dehaghi M, Molina DM, Farhadieh M, Morrow WJ, Liang X, Felgner PL, Grando SA.. New targets of pemphigus vulgaris antibodies identified by protein array technology. Exp Dermatol. 2011; 20:154–156.
   PubMed Web of Science ®Google Scholar
• Patel M, Furstenberg G, Hazelton J, Tiagi S, Seiffert-Sinha K, Haab BB, Robinson WH, Sinha AA.. Development of protein microarrays to investigate autoantibody profiles in pemphigus vulgaris. J Invest Dermatol. 2010; 130:S19 (abstract 549).
   Web of Science ®Google Scholar
• Talsma J, Stepanovich M, Chow S, Seiffert K, Sinha AA.. Dichotomy of anti-desmoglein 1 and -3 autoantibody profiles in pemphigus vulgaris patients carrying distinct HLA alleles. J Invest Dermatol. 2007; 127:16.
   PubMed Web of Science ®Google Scholar
• Dhandha M, Seiffert-Sinha K, Sinha AA. Specific immunoglobulin isotypes correlate with disease activity, morphology, duration, and HLA association in Pemphigus vulgaris (PV). J Invest Dermatol. 2009; 129:14.
   PubMed Web of Science ®Google Scholar
• Ayatollahi M, Joubeh S, Mortazavi H, Jefferis R, Ghaderi A.. IgG4 as the predominant autoantibody in sera from patients with active state of pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2004; 18:241–242.
   PubMed Web of Science ®Google Scholar
• Bhol K, Mohimen A, Ahmed AR. Correlation of subclasses of IgG with disease activity in pemphigus vulgaris. Dermatology. 1994; 189 Suppl 1: 85–89.
   PubMed Web of Science ®Google Scholar
• Kricheli D, David M, Frusic-Zlotkin M, Goldsmith D, Rabinov M, Sulkes J, Milner Y.. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br J Dermatol. 2000; 143:337–342.
   PubMed Web of Science ®Google Scholar
• Nagel A, Lang A, Engel D, Podstawa E, Hunzelmann M, de Pita O, Borradori L, Uter W, Hertl M.. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3. Clin Immunol. 2010; 134:320–330.
   PubMed Web of Science ®Google Scholar
• Spaeth S, Riechers R, Borradori L, Zillikens D, Bu¨dinger L, Hertl M.. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris. Br J Dermatol. 2001; 144:1183–1188.
   PubMed Web of Science ®Google Scholar
• Amagai M. Pemphigus vulgaris and its active disease mouse model. Curr Dir Autoimmun. 2008; 10:167–181.
   PubMedGoogle Scholar
• Anhalt GJ, Labib RS, Voorhees JJ, Beals TF, Diaz LA.. Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med. 1982; 306:1189–1196.
   PubMed Web of Science ®Google Scholar
• Cirillo N, Gombos F, Lanza A. Pemphigus vulgaris immunoglobulin G can recognize a 130–000 MW antigen other than desmoglein 3 on peripheral blood mononuclear cell surface. Immunology. 2007; 121:377–382.
   PubMed Web of Science ®Google Scholar
• Evangelista F, Dasher DA, Diaz LA, Prisayanh PS, Li N.. E-cadherin is an additional immunological target for pemphigus autoantibodies. J Invest Dermatol. 2008; 128:1710–1718.
   PubMed Web of Science ®Google Scholar
• Kurzen H, Brenner S. Significance of autoimmunity to non-desmoglein targets in pemphigus. Autoimmunity. 2006; 39:549–556.
   PubMed Web of Science ®Google Scholar
• Nguyen VT, Ndoye A, Shultz LD, Pittelkow MR, Grando SA.. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions. J Clin Invest. 2000; 106:1467–1479.
   PubMed Web of Science ®Google Scholar
• Patel M, Furstenberg G, Hazelton J, Tiagi S, Seiffert-Sinha K, Haab BB, Robinson WH, Sinha AA.. Development of protein microarrays to investigate autoantibody profiles in pemphigus vulgaris. J Invest Dermatol. 2010; 130:S19.
   Web of Science ®Google Scholar
• Grando SA. Autoimmunity to keratinocyte acetylcholine receptors in pemphigus. Dermatology. 2000; 201:290–295.
   PubMed Web of Science ®Google Scholar